Sex-specific perturbation of complex lipids in response to medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency

被引:11
|
作者
Alatibi, Khaled, I [1 ,2 ]
Wehbe, Zeinab [1 ,2 ]
Spiekerkoetter, Ute [3 ]
Tucci, Sara [1 ]
机构
[1] Univ Freiburg, Med Ctr, Fac Med, Lab Clin Biochem & Metab,Dept Gen Pediat & Adoles, Mathildenstr 1, D-79106 Freiburg, Germany
[2] Univ Freiburg, Fac Biol, Freiburg, Germany
[3] Univ Freiburg, Med Ctr, Fac Med, Dept Gen Pediat & Adolescent Med,Ctr Pediat & Ado, Freiburg, Germany
关键词
complex lipids; lysophosphatidylcholines; MCT; plasmalogens; sexual dimorphism; VLCAD; SPHINGOLIPID METABOLISM; CARDIOVASCULAR-DISEASE; MICE; CERAMIDE; TRIGLYCERIDES; HEALTH; PHOSPHATIDYLCHOLINE; BIOSYNTHESIS; INFLAMMATION; PLASMALOGENS;
D O I
10.1111/febs.15221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Very-long-chain acyl-CoA dehydrogenase deficiency (VLCAD) is the most common defect of long-chain fatty acid beta-oxidation. The recommended treatment includes the application of medium-chain triacylglycerols (MCTs). However, long-term treatment of VLCAD(-/-) mice resulted in the development of a sex-specific metabolic syndrome due to the selective activation of the ERK/mTORc1 signalling in females and ERK/peroxisome proliferator-activated receptor gamma pathway in males. In order to investigate a subsequent sex-specific effect of MCT on the lipid composition of the cellular membranes, we performed lipidomic analysis, SILAC-based quantitative proteomics and gene expression in fibroblasts from WT and VLCAD(-/-) mice of both sexes. Treatment with octanoate (C8) affected the composition of complex lipids resulting in a sex-specific signature of the molecular profile. The content of ceramides and sphingomyelins in particular differed significantly under control conditions and increased markedly in cells from mutant female mice but remained unchanged in cells from mutant males. Moreover, we observed a specific upregulation of biosynthesis of plasmalogens only in male mice, whereas in females C8 led to the accumulation of higher concentration of phosphatidylcholines and lysophosphatidylcholines. Our data on membrane lipids in VLCAD after supplementation with C8 provide evidence of a sex-specific lipid perturbation. We hypothesize a likely C8-induced pro-inflammatory response contributing to the development of a severe metabolic syndrome in female VLCAD(-/-) mice on long-term MCT supplementation.
引用
收藏
页码:3511 / 3525
页数:15
相关论文
共 50 条
  • [1] The fate of medium-chain fatty acids in very long-chain acyl-CoA dehydrogenase deficiency (VLCADD): A matter of sex?
    Wehbe, Zeinab
    Alatibi, Khaled
    Jellusova, Julia
    Spiekerkoetter, Ute
    Tucci, Sara
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, 1864 (11): : 1591 - 1605
  • [2] Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency
    Cox, Keith B.
    Liu, Jian
    Tian, Liqun
    Barnes, Stephen
    Yang, Qinglin
    Wood, Philip A.
    LABORATORY INVESTIGATION, 2009, 89 (12) : 1348 - 1354
  • [3] EFFECTS OF MEDIUM - CHAIN TRIGLYCERIDES ON FATTY ACID METABOLISM IN VERY LONG-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
    Spiekerkoetter, U.
    Tucci, S.
    ter Veld, F.
    Hoffmann, L.
    Primassin, S.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 52 - 52
  • [4] The Pathogenesis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
    Sharma, Shashwat
    Mckenzie, Matthew
    BIOMOLECULES, 2025, 15 (03)
  • [5] PRODUCTION AND DISPOSAL OF MEDIUM-CHAIN FATTY-ACIDS IN CHILDREN WITH MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY
    HEALES, SJR
    THOMPSON, GN
    MASSOUD, AF
    RAHMAN, S
    HALLIDAY, D
    LEONARD, JV
    JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (01) : 74 - 80
  • [6] Medium-chain acyl-CoA dehydrogenase deficiency in Spain
    Martinez, G
    Ribes, A
    Briones, P
    Rodés, M
    Baldellou, A
    Pineda, M
    Rodrigo, C
    Lorente, I
    García-Silva, MT
    Riudor, E
    Jaraba, P
    Lopez-Casas, J
    Nuñez-Roldan, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (06) : 693 - 694
  • [7] MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY
    EGIDIO, RJ
    FRANCIS, GL
    COATES, PM
    HALE, DE
    ROESEL, A
    AMERICAN FAMILY PHYSICIAN, 1989, 39 (05) : 221 - 226
  • [8] Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency
    Mayatepek, E
    Koch, HG
    Hoffmann, GF
    JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (06) : 842 - 843
  • [9] Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse
    Cox, KB
    Hamm, DA
    Millington, DS
    Matern, D
    Vockley, J
    Rinaldo, P
    Pinkert, CA
    Rhead, WJ
    Lindsey, JR
    Wood, PA
    HUMAN MOLECULAR GENETICS, 2001, 10 (19) : 2069 - 2077
  • [10] ESSENTIAL FATTY ACIDS IN PATIENTS WITH VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY
    Diekman, E. F.
    Visser, G.
    Houten, S. M.
    Vaz, F.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S153 - S153